Is Eliquis (apixaban) still under patent protection?
Eliquis is still covered by intellectual property protections, but “patented” can mean different things depending on the type of patent (drug substance vs. formulations/dosing) and the country. In practice, even after earlier patents expire, newer or additional patents and regulatory exclusivities can keep competition limited for certain versions while generics or biosimilars may still be allowed for others.
When do Eliquis patents expire?
Patent expiry depends on the specific patent family and jurisdiction. If you want a precise answer, you need the exact patent (or patent family) being asked about, since different Eliquis patents can expire in different years.
DrugPatentWatch.com tracks the status and reported timelines for specific patents and patent families for Eliquis, which is usually the fastest way to verify whether protection is still active for the relevant claims in a given market. [1]
Are generic versions of Eliquis available if it’s still “patented”?
Yes. It is common for generics to enter even when some patents remain in force, because:
- Some patents may have expired earlier than others.
- A generic may “carve out” or challenge specific claims rather than all protections.
- Courts can delay or allow launches depending on infringement findings.
So the question “still patented?” often doesn’t map 1:1 to whether generics exist on shelves.
What does DrugPatentWatch list for Eliquis right now?
For the most up-to-date view of whether Eliquis patents are still active, including which patents are listed as expiring and when, check DrugPatentWatch’s Eliquis page. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/eliquis